A Study to Compare the Efficacy and Safety of Levofloxacin in the Treatment of Children With Community-acquired Pneumonia in the Hospital or Outpatient Setting
Completed
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 3
2002-08-01
The purpose of this study is to determine the safety and efficacy of levofloxacin in the
treatment of children with community acquired pneumonia.
Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia
Terminated
Biomedical Advanced Research and Development Authority
Phase 2/Phase 3
2016-04-01
This is a phase 2/3, randomized, open-label, active control, multi-center study to assess the
safety and efficacy of solithromycin in children and adolescents with community-acquired
bacterial pneumonia (CABP).
Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia
Terminated
Cempra Inc
Phase 2/Phase 3
2016-04-01
This is a phase 2/3, randomized, open-label, active control, multi-center study to assess the
safety and efficacy of solithromycin in children and adolescents with community-acquired
bacterial pneumonia (CABP).
Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia
Terminated
Melinta Therapeutics, Inc.
Phase 2/Phase 3
2016-04-01
This is a phase 2/3, randomized, open-label, active control, multi-center study to assess the
safety and efficacy of solithromycin in children and adolescents with community-acquired
bacterial pneumonia (CABP).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
